A clinicoetiological study of Stevens-Johnson syndrome and toxic epidermal necrolysis

Journal of Pakistan Association of Dermatologists

Volumn 23, Issue 1, 2013, Pages 5-13

  Gardezi, Syed Ahmad Ali ^a   Kazmi, Atif Hasnain ^a   Aman, Shahbaz ^a   Nadeem, Muhammad ^a   Khan, Muhammad Salim ^a   Sohail, Masood ^a  

^a KING EDWARD MEDICAL UNIVERSITY   (Pakistan)

Author keywords

Erythema multiforme; Stevens Johnson syndrome; Toxic epidermal necrolysis

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; AMOXICILLIN; CARBAMAZEPINE; CEFRADINE; CHLOROQUINE; CIPROFLOXACIN; CLARITHROMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; DIPYRONE; DOXYCYCLINE; GENTAMICIN; HALOPERIDOL; LEVOFLOXACIN; MEFENAMIC ACID; PARACETAMOL;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE STUDY; CHILD; CLINICAL ARTICLE; DEHYDRATION; DESCRIPTIVE RESEARCH; DISEASE SEVERITY; EAR DISEASE; EPIDERMIS; EYE DISEASE; FEMALE; GASTROINTESTINAL SYMPTOM; HOSPITAL DISCHARGE; HUMAN; LENGTH OF STAY; MALE; MORBIDITY; MORTALITY; OLIGURIA; OUTCOME ASSESSMENT; PAIN; RESPIRATORY TRACT DISEASE; SCHOOL CHILD; SCORING SYSTEM; SKIN INFECTION; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; UROGENITAL TRACT DISEASE; VAGINA DISEASE; WOUND INFECTION;

EID: 84878373366     PISSN: 15609014     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Klein PA, Dirk M, Elston DE. Dermatologic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis [online] 2011 Oct 20 last update. Available from: URL: http://emedicine.medscape.com/article/1124 127-overview#aw2aab6b3
2. Martin T, Hui LI.Severe cutaneous adverse drug reactions: a review on epidemiology, etiology, clinical manifestation and pathogenesis. Chin Med J. 2008;121:756-61.
3. Halevy S. Stevens-Johnson syndrome and toxic epidermal necrolysis--updates and innovations. Harefuah. 2010;149:186-90, 193.
4. Yapp FBB, Wahiduzzaman M, Pubalan M. Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in Sarawak: A four years review. Egyp Dermatol Online J. 2008;4:1.
5. Lissia M, Mulas P, Bulla A et al. Toxic epidermal necrolysis (Lyell's disease). Burns. 2010;36;152-63.
6. Koh MJ, Tay YK. An update on Stevens- Johnson syndrome and toxic epidermal necrolysis in children. Curr Opin Pediatr. 2009;21:505-10.
7. Ahmed YI, Azeem S, Khan O et al. Stevens- Johnson syndrome in Pakistan: a ten year survey. J Pak Med Assoc. 2004;54:312-5.
8. Foster SC, Letko E. Stevens-Johnson syndrome [online] 2007 Dec 18 last update. [Cited 2007 Dec 20]. Available from: URL:http://www.emedicine.com/oph/topic2 68.html
9. Sanmarkan AD, Sori T, Thappa DM, Jaisankar TJ. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis over a period of 10 years. Indian J Dermatol. 2011;56:25-9.
10. Wolkenstein P, Revuz J. Toxic epidermal necrolysis. Dermatol Clin 2000;18:485-95.
11. Levi N, Bastuji-Garin S, Mockenhaupt M et al. Medications as risk factors of Stevens- Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis. Pediatrics. 2009;123:e297-304.
12. Barvaliya M, Sanmukhani J, Patel T et al. Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study. Postgrad Med. 2011;57:115-9.
13. Martin T, Li H. Severe cutaneous adverse drug reactions: a review on epidemiology, etiology, clinical manifestation and pathogenesis. Chin Med J (Engl). 2008;121:756-61.
14. Parrillo SJ, Parrillo CV. Stevens Johnson Syndrome [online] 2007 Feb 22 last update. [cited 2007 Dec 21]. Available from: URL:http://www.emedicine.com/EMERG/to pic555.html.
15. de Prost N, Ingen-Housz-Oro S, Duong T et al. Bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: epidemiology, risk factors, and predictive value of skin cultures. Medicine (Baltimore). 2010;89:28-36.
16. French LE. Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding. Allergol Int. 2006;55:9-16.
17. Gurcan HM, Ahmed AR. Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders. Ann Pharmacother. 2007;41:812-23.
18. Burk M, Sood A. Acute pulmonary manifestations of toxic epidermal necrolysis. J Burns Surg Wound Care. 2003;2:6. [cited 2007 Dec 24]. Available from: URL:http://www.journalofburns.com.